---
title: "Docmode Health Technologies Ltd (DHTL) — Share Price, Financials & Analysis"
symbol: "DHTL"
company: "Docmode Health Technologies Ltd"
canonical: "https://tapetide.com/stocks/DHTL"
isin: "INE0OGG01015"
nse_symbol: "DHTL"
sector: "Consumer Services"
industry: "E-Learning"
market_cap_cr: 10.75
generated_at: "2026-09-13T18:57:17.038Z"
---

# Docmode Health Technologies Ltd (DHTL)

Canonical page: https://tapetide.com/stocks/DHTL

## Company

- **NSE Symbol:** DHTL
- **ISIN:** INE0OGG01015
- **Sector:** Consumer Services
- **Industry:** E-Learning
- **Macro Sector:** Consumer Discretionary
- **Stock Type:** EQUITY
- **Listed Since:** 2024-02-02
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** docmode.org

## About

Incorporated in 2017, Doctrack Solutions Ltd is engaged in the business of offering integrated learning solutions through online and offline learning models to healthcare professionals and learners.[1]

## Latest Price

- **Price:** ₹32.5
- **Change:** -1.7 (-4.97%)
- **Open:** ₹32.55
- **Day High:** ₹32.55
- **Day Low:** ₹32.5
- **Previous Close:** ₹34.2
- **Volume:** 11200
- **As Of:** 2026-09-11T07:38:26+00:00

## Key Fundamentals

Observed at 2026-09-11T04:51:56.932011Z.

- **Market Cap:** ₹10.75 Cr
- **Classification:** SME
- **P/E (reported):** -79.5
- **Book Value:** ₹26.13
- **Price to Book:** 1.31
- **Dividend Yield:** 0%
- **ROE:** -24.27%
- **ROCE:** -0.46%
- **Debt to Equity:** 0.45
- **Revenue (yearly):** ₹25.52 Cr
- **Net Income:** ₹-0.14 Cr
- **EBITDA:** ₹-0.33 Cr
- **52-Week High:** ₹125.2
- **52-Week Low:** ₹29.9
- **RSI (14):** 46.91

## Tapetide Score

- **Score:** 47 / 100
- **Score date:** 2026-08-25
- **Archetype:** Out of Favour
- **What it means:** Financially sound, yet the market is not rewarding it. Cases like this usually need a specific reason the pessimism is misplaced, and patience for that reason to play out.
- **Pillar profile:** Quality: Good · Valuation: Cheap · Momentum: Falling
- **Percentile:** 35.8 (of 4467 scored stocks)
- **Confidence:** 84%
- **Data coverage:** 67%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 12.75 | 9% |
| growth | 51.33 | 9% |
| momentum | 10.2 | 12% |
| ownership | 43 | 24% |
| quality | 64.92 | 22% |
| valuation | 65.31 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has reduced debt.

### Weaknesses

- Company has low interest coverage ratio.
- Promoter holding has decreased over last quarter: -1.36%
- Promoter holding is low: 29.5%
- Company has a low return on equity of -8.02% over last 3 years.
- Promoters have pledged 37.4% of their holding.
- Earnings include an other income of Rs.1.40 Cr.
- Company's cost of borrowing seems high

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| cash flow growth | 48.12% | 904.82% | — |
| ebitda margin growth | -308.47% | -124.4% | -108.05% |
| net income growth | -93% | -170% | -115.56% |
| revenue growth | -40.23% | -8% | 29% |
| roce | -103.55% | -101.01% | 32.07% |
| roe | — | 11.2% | -120.41% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 20.02 | 23.6 | 16.4 | 20.42 | 21.35 | 17.85 | 7.67 |
| Expenses | 18.58 | 20.88 | 17.23 | 20.54 | 21.97 | 17.05 | 8.83 |
| Operating Profit | 1.44 | 2.72 | -0.83 | -0.12 | -0.62 | 0.8 | -1.16 |
| OPM % | 7.19 | 11.53 | -5.06 | -0.59 | -2.9 | 4.48 | -15.12 |
| Other Income | 0.05 | 0.06 | 0.07 | 0.84 | 0.09 | 0.07 | 1.32 |
| Interest | 0.72 | 0.84 | 0.82 | 1.09 | 0.83 | 0.85 | 0.11 |
| Depreciation | 0.01 | 0.02 | 0.01 | 0.14 | 0.16 | 0.11 | 0.12 |
| Profit before tax | 0.76 | 1.92 | -1.59 | -0.51 | -1.52 | -0.09 | -0.07 |
| Tax % | 18.42 | 29.17 | -25.79 | 1.96 | 3.95 | 0 | 0 |
| Net Profit | 0.61 | 1.36 | -1.17 | -0.52 | -1.58 | -0.09 | -0.07 |
| EPS in Rs | 2.66 | 5.93 | -3.72 | -1.65 | -5.03 | -0.29 | -0.22 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 6.94 | 7.1 | 12.42 | 32.88 | 39.93 | 41.71 | 25.52 |
| Expenses | 6.55 | 6.23 | 10.53 | 29.14 | 38.05 | 42.39 | 25.86 |
| Operating Profit | 0.39 | 0.87 | 1.89 | 3.74 | 1.88 | -0.68 | -0.34 |
| OPM % | 5.62 | 12.25 | 15.22 | 11.37 | 4.71 | -1.63 | -1.33 |
| Other Income | 0 | 0 | 0.01 | 0.1 | 0.14 | 0.93 | 1.4 |
| Interest | 0.01 | 0.19 | 0.38 | 1.13 | 1.66 | 1.92 | 0.97 |
| Depreciation | 0.05 | 0.04 | 0.02 | 0.02 | 0.02 | 0.3 | 0.23 |
| Profit before tax | 0.33 | 0.64 | 1.5 | 2.69 | 0.34 | -1.97 | -0.14 |
| Tax % | -6.06 | 14.06 | 38.67 | 27.51 | 44.12 | 3.05 | -7.14 |
| Net Profit | 0.34 | 0.55 | 0.92 | 1.95 | 0.19 | -2.03 | -0.13 |
| EPS in Rs | — | — | — | 8.5 | 0.6 | -6.46 | -0.41 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 0.01 | 0.01 | 0.01 | 2.29 | 3.14 | 3.14 | 3.14 |
| Reserves | -0.1 | 0.46 | 1.38 | 1.18 | 7.23 | 5.21 | 5.07 |
| Borrowings | 0.02 | 1.06 | 4.84 | 8.48 | 9.18 | 6.82 | 3.73 |
| Other Liabilities | 1.96 | 4.14 | 3.85 | 5.06 | 10.6 | 24.14 | 21.56 |
| Total Liabilities | 1.89 | 5.67 | 10.08 | 17.01 | 30.15 | 39.31 | 33.5 |
| Fixed Assets | 0.15 | 0.16 | 0.5 | 2.07 | 0.97 | 1.22 | 14.46 |
| CWIP | 0 | 0 | 0 | 0 | 8.5 | 11.6 | 0 |
| Investments | 0 | 0.1 | 1.25 | 1.2 | 1.26 | 1.29 | 1.3 |
| Other Assets | 1.74 | 5.41 | 8.33 | 13.74 | 19.42 | 25.2 | 17.74 |
| Total Assets | 1.89 | 5.67 | 10.08 | 17.01 | 30.15 | 39.31 | 33.5 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 0.17 | -0.5 | -2.05 | -0.83 | 4.51 | 6.68 | 4.3 |
| Cash from Investing Activity | -0.2 | -0.13 | -1.52 | -1.57 | -7.55 | -3.67 | -1.89 |
| Cash from Financing Activity | 0.01 | 0.84 | 3.41 | 2.65 | 5.76 | -4.28 | -4.06 |
| Net Cash Flow | -0.03 | 0.21 | -0.17 | 0.25 | 2.72 | -1.27 | -1.66 |
| Free Cash Flow | -0.03 | -0.54 | -2.42 | -2.43 | -2.91 | 3.03 | 2.42 |
| CFO/OP | 46 | -57 | -103 | -22 | 239 | -1001 | -1265 |

### Ratios

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 0.53 | 69.92 | 112.26 | 92.03 | 104.85 | 80.86 | 106.41 |
| Inventory Days | 120.77 | 668.83 | 501.37 | — | — | — | 142.15 |
| Days Payable | 60.38 | 511.82 | 322.88 | — | — | — | 64.56 |
| Cash Conversion Cycle | 60.91 | 226.93 | 290.75 | 92.03 | 104.85 | 80.86 | 184 |
| Working Capital Days | -22.62 | 30.33 | 92.28 | 50.07 | 11.61 | -54.17 | -94.11 |
| ROCE % | — | 113.7 | 48.45 | 42.02 | 12.7 | -0.29 | 6.12 |

## Shareholding Pattern

### Quarterly

| Category | Mar 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Promoters | 47.44% | 47.44% | 47.44% | 47.44% | 30.86% | 29.5% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 44.01% | 49.25% | 50.06% | 48.97% | 64.71% | 65.31% |
| Others | 8.55% | 3.31% | 2.49% | 3.59% | 4.43% | 5.19% |
| No. of Shareholders | 238 | 259 | 262 | 246 | 221 | 195 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 1 / 7 / 11

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 32.56 | Sell |
| EMA (10) | 33.02 | Sell |
| SMA (20) | 33.77 | Sell |
| EMA (20) | 33.95 | Sell |
| SMA (50) | 36.3 | Sell |
| EMA (50) | 36.72 | Sell |
| SMA (100) | 39.23 | Sell |
| EMA (100) | 41.8 | Sell |
| SMA (200) | 52.32 | Sell |
| EMA (200) | 47.17 | Sell |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 45.39 | Neutral |
| MACD (12,26,9) | -1.36 | Buy |
| Stochastic (14,3,3) | 62.75 | Neutral |
| ADX (14) | 9.23 | Neutral |
| Williams %R (14) | -49.02 | Neutral |
| ATR (14) | 2.17 | High Volatility |
| ROC (12) | -3.99 | Sell |
| Stoch RSI (14) | 53.08 | Neutral |
| UO (7,14,28) | 62.92 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 9 Jul - EGM shareholders approved change in company name and related MoA/AoA amendments on 8 July 2026. | [Shareholders meeting 9 Jul - EGM shareholders approved change in company name and related MoA/AoA amendments on 8 July 2026.](https://nsearchives.nseindia.com/corporate/DOCMODE_09072026192303_OutcomeofVotingResult_EGM_08072026_Docmode.pdf) |
| 9 Jul - Docmode Health Technologies Limited has informed about Certificate under SEBI (Depositories and Participants) Regulations, 2018 | [Certificate under SEBI (Depositories and Participants) Regulations, 2018 9 Jul - Docmode Health Technologies Limited has informed about Certificate under SEBI (Depositories and Participants) Regulations, 2018](https://nsearchives.nseindia.com/corporate/DOCMODE_09072026135733_Disclosure_Regulation74_SebiDPReg_Docmode.pdf) |
| 9 January 2026 - RTA certificate under SEBI Reg 74(5) for quarter ended 31-Dec-2025; no rematerialisation requests. | [Certificate under SEBI (Depositories and Participants) Regulations, 2018 9 January 2026 - RTA certificate under SEBI Reg 74(5) for quarter ended 31-Dec-2025; no rematerialisation requests.](https://nsearchives.nseindia.com/corporate/DOCMODE_09012026153219_Disclosure_Regulation74_SebiDPReg_Docmode.pdf) |
| 9 January 2026 - Reconciliation report for quarter ended 31-Dec-2025; issued capital 3,142,800 shares; CS resigned, interim compliance officer appointed. | [Updates 9 January 2026 - Reconciliation report for quarter ended 31-Dec-2025; issued capital 3,142,800 shares; CS resigned, interim compliance officer appointed.](https://nsearchives.nseindia.com/corporate/DOCMODE_09012026164431_Disclosure_ReconciliationofShareCapitalAudit_docmode.pdf) |
| 8 Jul - EGM held on 8 July 2026 for approving company name change and related amendments. | [Shareholders meeting 8 Jul - EGM held on 8 July 2026 for approving company name change and related amendments.](https://nsearchives.nseindia.com/corporate/DOCMODE_08072026153945_OutcomeofEGM_08072026_Docmode_signed.pdf) |
| 8 April 2026 - Filed share capital audit report for quarter ended 31 March 2026; compliance officer transition noted. | [Updates 8 April 2026 - Filed share capital audit report for quarter ended 31 March 2026; compliance officer transition noted.](https://nsearchives.nseindia.com/corporate/DOCMODE_08042026155318_Disclosure_ReconciliationofShareCapitalAudit.pdf) |
| 8 April 2026 - Board approved revised EGM notice and rescheduled EGM to 8 May 2026 at 2:00 PM. | [Shareholders meeting 8 April 2026 - Board approved revised EGM notice and rescheduled EGM to 8 May 2026 at 2:00 PM.](https://nsearchives.nseindia.com/corporate/DOCMODE_08042026161403_DisclosureofscheduleofEGM_NSE_Docmode_revised.pdf) |
| 7 Sep - 9th AGM on 30 Sep 2026; seeks approval for Rs 30 crore FY27 related party transactions. | [Shareholders meeting 7 Sep - 9th AGM on 30 Sep 2026; seeks approval for Rs 30 crore FY27 related party transactions.](https://nsearchives.nseindia.com/corporate/DOCMODE_07092026184147_Intimation_of_AGM_Doctrack_final.pdf) |
| 7 April 2026 - RTA confirms Regulation 74(5) compliance for quarter ended 31 March 2026; no rematerialisation requests. | [Certificate under SEBI (Depositories and Participants) Regulations, 2018 7 April 2026 - RTA confirms Regulation 74(5) compliance for quarter ended 31 March 2026; no rematerialisation requests.](https://nsearchives.nseindia.com/corporate/DOCMODE_07042026194106_Disclosure_Regulation_74_SebiDPReg_Docmode.pdf) |
| 6 May 2026 - Board rescheduled the EGM to 8 June 2026 at 2:00 PM and approved revised notice. | [Shareholders meeting 6 May 2026 - Board rescheduled the EGM to 8 June 2026 at 2:00 PM and approved revised notice.](https://nsearchives.nseindia.com/corporate/DOCMODE_06052026192149_5_Intimationofreschedule_of_EGM_Docmode.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2026 from nse](https://archives.nseindia.com/annual_reports/SME_AR_31713_DHTL_2025_2026_A_2500963_07092026173815.pdf) |
| from nse | [Annual Report 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_27918_DHTL_2024_2025_A_2628295_29082025194259.pdf) |
| from nse | [Annual Report 2024 from nse](https://archives.nseindia.com/annual_reports/SME_AR_25363_DHTL_2023_2024_3108202413945.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:57:17.038Z.